Tumor responses
| All patients (N=36) | Primary tumor type | ||
| Bladder cancer (n=18) | Other types (n=18) | ||
| Best overall response, n (%) | |||
| Complete response | 1 (2.8) | 1 (5.6) | 0 |
| Partial response | 10 (27.8) | 6 (33.3) | 4 (22.2) |
| Stable disease | 12 (33.3) | 7 (38.9) | 5 (27.8) |
| Progressive disease | 10 (27.8) | 3 (16.7) | 7 (38.9) |
| Not evaluable | 3 (8.3) | 1 (5.6) | 2 (11.1) |
| Objective response rate, % (95% CI) | 30.6 (16.3 to 48.1) | 38.9 (17.3 to 64.3) | 22.2 (6.4 to 47.6) |
| Disease control rate, % (95% CI) | 63.9 (46.2 to 79.2) | 77.8 (52.4 to 93.6) | 50.0 (26.0 to 74.0) |
| Median time to response (range), months | 2.1 (1.9–2.1) | 2.1 (2.0–2.1) | 2.1 (1.9–2.1) |
| Duration of response | |||
| Patients with ongoing response, n/N (%) | 5/11 (45.5) | 4/7 (57.1) | 1/4 (25.0) |
| Median (95% CI) | 6.3 (2.1 to NR) | NR (4.2 to NR) | 4.2 (2.1 to NR) |
| 6-month rate | 72.7% (37.1 to 90.3) | 85.7% (33.4 to 97.9) | 50.0% (5.8 to 84.5) |
NR, not reached.